Director, Quality Compliance

We are seeking an innovative and highly motivated Director, Quality Compliance, who will contribute significantly to the growth of the Cellares team.  

This individual will be responsible for leading Quality Compliance activities for the Bridgewater site.  They will be identifying and assessing regulatory and quality risks during site GMP operations ensuring adherence to global regulations and Cellares’ policies and procedures. This individual will be responsible for leading the continuous inspection readiness efforts and the site's self-inspection program.  They will manage routine use of the Cellares Quality Management Systems 

Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.

We are seeking an innovative and highly motivated Director, Quality Compliance, who will contribute significantly to the growth of the Cellares team.  

This individual will be responsible for leading Quality Compliance activities for the Bridgewater site.  They will be identifying and assessing regulatory and quality risks during site GMP operations ensuring adherence to global regulations and Cellares’ policies and procedures. This individual will be responsible for leading the continuous inspection readiness efforts and the site's self-inspection program.  They will manage routine use of the Cellares Quality Management Systems 

Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.